Hepatocellular Carcinoma Treatment and Prognosis
Most cited papers
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine · 2008 · 13,250 citations
- Preoperative assessment of liver function: a comparison of 99mTc‐Mebrofenin scintigraphy with indocyanine green clearance testLiver International · 2004 · 11,692 citations
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology · 2011 · 8,141 citations
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular CarcinomaNew England Journal of Medicine · 2020 · 7,704 citations
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine · 1996 · 7,213 citations
- Management of Hepatocellular Carcinoma *Hepatology · 2005 · 5,941 citations
- Sunitinib versus Interferon Alfa in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine · 2007 · 5,822 citations
- Acute Abdomen: A Rare Case of Ruptured Hepatocellular CarcinomaCase Reports in Gastroenterology · 2017 · 5,385 citations
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology · 2012 · 5,281 citations
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine · 2007 · 4,843 citations
- Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology · 2018 · 4,629 citations
- Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSeminars in Liver Disease · 2010 · 4,413 citations
- AASLD guidelines for the treatment of hepatocellular carcinomaHepatology · 2017 · 4,121 citations
Metadata from OpenAlex (CC0).